Vanda Pharma Q3 EPS $(0.37) Beats $(0.68) Estimate, Sales $69.815M Beat $69.202M Estimate
Vanda Pharma (NASDAQ:VNDA) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.68) by 45.59 percent. This is a 2.63 percent increase over losses of $(0.38) per share from the